Clostridioides Difficile Infection Recurrence
8 clinical trials · Condition
◉ Watch Clostridioides Difficile Infection Recurrence
| Record | Firm | Date |
|---|---|---|
| Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection (NCT05304715) | Hellenic Institute for the Study of Sepsis | 2022-04-13 |
| Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT03788434) | Vedanta Biosciences, Inc. | 2019-02-08 |
Track Clostridioides Difficile Infection Recurrence automatically
Every clearance here is in the API, with alerts when new ones post.